Publications by Lorena Arranz

14 publications found

Publications 2025

  1. Bernal A, Cuminetti V, Serulla M, Florit A, Konieczny J, Golnarnik G, Chen Y, Ferré M, Geiseler S, Vik A, Olsen R, Arranz L (2025)
    Bone marrow sympathetic neuropathy is a hallmark of hematopoietic malignancies and it involves severe ultrastructural damage
    14 (1), 31
    DOI 10.1186/s40164-025-00614-x, PubMed 40045344

Publications 2023

  1. Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
    Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
    14 (1), 12
    DOI 10.1038/s41467-022-35700-9, PubMed 36596811
  2. Villatoro A, Cuminetti V, Bernal A, Torroja C, Cossío I, Benguría A, Ferré M, Konieczny J, Vázquez E, Rubio A, Utnes P, Tello A, You X, Fenton CG, Paulssen RH, Zhang J, Sánchez-Cabo F, Dopazo A, Vik A, Anderssen E, Hidalgo A, Arranz L (2023)
    Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation
    14 (1), 3874
    DOI 10.1038/s41467-023-39601-3, PubMed 37391415

Publications 2022

  1. Arranz L (2022)
    The Hematology of Tomorrow Is Here-Preclinical Models Are Not: Cell Therapy for Hematological Malignancies
    14 (3)
    DOI 10.3390/cancers14030580, PubMed 35158848
  2. Vilaplana-Lopera N, Cuminetti V, Almaghrabi R, Papatzikas G, Rout AK, Jeeves M, González E, Alyahyawi Y, Cunningham A, Erdem A, Schnütgen F, Raghavan M, Potluri S, Cazier JB, Schuringa JJ, Reed MAC, Arranz L, Günther UL, Garcia P (2022)
    Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells
    11
    DOI 10.7554/eLife.75908, PubMed 36052997

Publications 2021

  1. De Toda IM, Rattan SIS, De la Fuente M, Arranz L (2021)
    Female Mice Reaching Exceptionally High Old Age Have Preserved 20S Proteasome Activities
    Antioxidants, 10 (9), 1397
    DOI 10.3390/antiox10091397
  2. Mate I, de Toda IM, Arranz L, Alvarez-Sala JL, De la Fuente M (2021)
    Accelerated immunosenescence, oxidation and inflammation lead to a higher biological age in COPD patients
    Exp. Gerontol., 154, 111551
    DOI 10.1016/j.exger.2021.111551

Publications 2020

  1. Villatoro A, Konieczny J, Cuminetti V, Arranz L (2020)
    Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
    8, 607
    DOI 10.3389/fcell.2020.00607, PubMed 32754595

Publications 2019

  1. Cuminetti V, Arranz L (2019)
    Bone Marrow Adipocytes: The Enigmatic Components of the Hematopoietic Stem Cell Niche
    8 (5)
    DOI 10.3390/jcm8050707, PubMed 31109063

Publications 2018

  1. Bernal A, Arranz L (2018)
    Nestin-expressing progenitor cells: function, identity and therapeutic implications
    Cell. Mol. Life Sci., 75 (12), 2177-2195
    DOI 10.1007/s00018-018-2794-z
  2. Grimolizzi F, Arranz L (2018)
    Multiple faces of succinate beyond metabolism in blood
    Haematologica, 103 (10), 1586-1592
    DOI 10.3324/haematol.2018.196097
  3. Konieczny J, Arranz L (2018)
    Updates on Old and Weary Haematopoiesis
    Int. J. Mol. Sci., 19 (9), 2567
    DOI 10.3390/ijms19092567
  4. Thiyagarajan D, Pedersen HL, Seredkina N, Horvei KD, Arranz L, Sonneveld R, Nijenhuis T, van der Vlag J, Rekvig OP (2018)
    IL-1 beta Promotes a New Function of DNase I as a Transcription Factor for the Fas Receptor Gene
    Front. Cell. Dev. Biol., 6, 7
    DOI 10.3389/fcell.2018.00007

Publications 2017

  1. Arranz L, Arriero MD, Villatoro A (2017)
    Interleukin-1 beta as emerging therapeutic target in hematological malignancies and potentially in their complications
    Blood Rev., 31 (5), 306-317
    DOI 10.1016/j.blre.2017.05.001